![Gonorrhea: What’s Currently in the Clinical Pipeline?](https://thenativeantigencompany.com/wp-content/uploads/2020/02/shutterstock_1315455335-1000x675.jpg)
![Gonorrhea: What’s Currently in the Clinical Pipeline?](https://thenativeantigencompany.com/wp-content/uploads/2020/02/shutterstock_1315455335-1000x675.jpg)
![Novel Coronavirus Antigens Now Available](https://thenativeantigencompany.com/wp-content/uploads/2020/02/shutterstock_724091662-min-1-1-1080x675.jpg)
Novel Coronavirus Antigens Now Available
The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and vaccines. S1 Glycoprotein S2...![The Why and How of Protein Conjugation](https://thenativeantigencompany.com/wp-content/uploads/2020/02/shutterstock_721937668.jpg)